On February 8, 2024, GSK plc awarded conditional share awards to senior executives involving 1,098,958 shares at a price of £16.726 each under their 2017 Performance Share Plan, with targets based on shareholder return and sales growth. This significant event aims to incentivize management performance until the end of 2026.